摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-isopropyl-2-phenyl-1H-benzo[d]imidazole | 305347-11-9

中文名称
——
中文别名
——
英文名称
1-isopropyl-2-phenyl-1H-benzo[d]imidazole
英文别名
2-phenyl-1-iso-propylbenzimidazole;1-isopropyl-2-phenylbenzimidazole;2-Phenyl-1-propan-2-ylbenzimidazole
1-isopropyl-2-phenyl-1H-benzo[d]imidazole化学式
CAS
305347-11-9
化学式
C16H16N2
mdl
MFCD01815876
分子量
236.316
InChiKey
JNAYENKNLFJCBE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.8
  • 重原子数:
    18
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.19
  • 拓扑面积:
    17.8
  • 氢给体数:
    0
  • 氢受体数:
    1

反应信息

  • 作为反应物:
    描述:
    iridium(III) chloride trihydrate 、 1-isopropyl-2-phenyl-1H-benzo[d]imidazole 为溶剂, 生成
    参考文献:
    名称:
    具有吡啶甲酸辅助配体的中性 2-苯基苯并咪唑基铱 (III) 配合物:通过操纵苯并咪唑环上的取代基来调节发射特性
    摘要:
    我们报道了十种中性二杂杂铱( III )配合物的合成和表征,其中2-苯基苯并咪唑环金属化配体和吡啶甲酸作为辅助配体。 2-苯基苯并咪唑已通过在环金属化环和/或苯并咪唑部分上引入的选定取代基进行修饰。复合物的完整性已通过核磁共振波谱、高分辨率质谱和元素分析进行​​了评估。该配合物被证明在室温下具有高度磷光性,并且通过全面的从头计算进行的发光研究使我们能够确定最低发射激发态,这取决于取代基的性质及其在环金属化配体上的位置。
    DOI:
    10.1039/d3dt03498d
  • 作为产物:
    描述:
    N1-benzyl-N1-isopropylbenzene-1,2-diamine 在 bis(1,5-cyclooctadiene)diiridium(I) dichloride 作用下, 以 2,2,2-三氟乙醇 为溶剂, 反应 72.0h, 以74%的产率得到1-isopropyl-2-phenyl-1H-benzo[d]imidazole
    参考文献:
    名称:
    Synthesis of benzimidazoles via iridium-catalyzed acceptorless dehydrogenative coupling
    摘要:
    苯并咪唑类化合物通过铱催化的受体无氧脱氢偶联反应,产率较高。
    DOI:
    10.1039/c5ob00904a
点击查看最新优质反应信息

文献信息

  • Phenoxypiperidines and analogs thereof useful as histamine H3 antagonists
    申请人:Mutahi W. Mwangi
    公开号:US20070167435A1
    公开(公告)日:2007-07-19
    Disclosed are compounds of the formula or a pharmaceutically acceptable salt or solvate thereof, wherein: M is CH or N; U and W are each CH, or one of U and W is CH and the other is N; X is a bond, alkylene, —C(O)—, —C(N—OR 5 )—, —C(N—OR 5 )—CH(R 6 )—, —CH(R 6 )—C(N—OR 5 )—, —O—, —OCH 2 —, —CH 2 O— or —S(O) 0-2 —; Y is —O—, —(CH 2 ) 2 —, —C(═O)—, —C(═NOR 7 )— or —SO 0-2 —; Z is a bond, optionally substituted alkylene or alkylene interrupted by a heteroatom or heterocyclic group; R 1 is optionally substituted alkyl, cycloalkyl, aryl, arylalkyl, heteroaryl, heterocycloalkyl, or benzimidazolyl or a derivative thereof; R 2 is optionally substituted alkyl, alkenyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl or heterocycloalkyl; and the remaining variables are as defined in the specification; compositions and methods for treating an allergy-induced airway response, congestion, diabetes, obesity, an obesity-related disorder, metabolic syndrome and a cognition deficit disorder using said compounds, alone or in combination with other agents.
    揭示了以下化合物的结构式或其药学上可接受的盐或溶剂,其中:M为CH或N;U和W分别为CH,或者U和W中的一个为CH,另一个为N;X为键,烷基,—C(O)—,—C(N—OR5)—,—C(N—OR5)—CH(R6)—,—CH(R6)—C(N—OR5)—,—O—,—OCH2—,—CH2O—或—S(O)0-2—;Y为—O—,—(CH2)2—,—C(═O)—,—C(═NOR7)—或—SO0-2—;Z为键,可选择地取代的烷基或被杂原子或杂环基中断的烷基;R1为可选择地取代的烷基,环烷基,芳基,芳基烷基,杂芳基,杂环烷基或苯并咪唑基或其衍生物;R2为可选择地取代的烷基,烯基,芳基,芳基烷基,杂芳基,杂芳基烷基,环烷基或杂环烷基;其余变量如规范中所定义;使用这些化合物,单独或与其他药剂联合使用,治疗由过敏引起的气道反应、充血、糖尿病、肥胖症、与肥胖有关的疾病、代谢综合征和认知缺陷障碍的组合物和方法。
  • Synthesis of benzimidazoles via iridium-catalyzed acceptorless dehydrogenative coupling
    作者:Xiang Sun、Xiao-Hui Lv、Lin-Miao Ye、Yu Hu、Yan-Yan Chen、Xue-Jing Zhang、Ming Yan
    DOI:10.1039/c5ob00904a
    日期:——

    Benzimidazoles were prepared in good yieldsviathe iridium-catalyzed acceptorless dehydrogenative coupling of tertiary amines and arylamines.

    苯并咪唑类化合物通过铱催化的受体无氧脱氢偶联反应,产率较高。
  • FUSED POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING THE COMPOUND
    申请人:Ohrui Hiroki
    公开号:US20120306727A1
    公开(公告)日:2012-12-06
    Provided are a fused polycyclic compound suitable for use mainly as a component for a blue-light-emitting device, and an organic light-emitting device using the compound. The fused polycyclic compound is represented by the general formulae (1), (2), (8) and (9).
    提供了一种适用于主要用作蓝光发射装置组分的融合多环化合物,以及使用该化合物的有机发光装置。融合多环化合物由一般式(1)、(2)、(8)和(9)表示。
  • Compounds and Methods for Treating Mammalian Gastrointestinal Microbial Infections
    申请人:Hedstrom Lizbeth K.
    公开号:US20120101096A1
    公开(公告)日:2012-04-26
    Described herein are compounds, and pharmaceutically acceptable salts and prodrugs thereof, which are useful as inhibitors of IMPDH. In certain embodiments, a compound of the invention selectively inhibits a parasitic IMPDH versus a host IMPDH. Further, the invention provides pharmaceutical compositions comprising one or more compounds of the invention. The invention also relates to methods of treating various parasitic and bacterial infections in mammals. Moreover, the compounds may be used alone or in combination with other therapeutic or prophylactic agents, such as anti-virals, anti-inflammatory agents, antimicrobials and immunosuppressants.
    本文描述了一些化合物,以及其药用盐和前药,这些化合物可用作IMPDH的抑制剂。在某些实施例中,本发明的化合物选择性地抑制寄生物IMPDH而不抑制宿主IMPDH。此外,本发明提供了包含一种或多种本发明化合物的药物组合物。本发明还涉及治疗哺乳动物中各种寄生虫和细菌感染的方法。此外,这些化合物可以单独使用或与其他治疗或预防剂(如抗病毒药物、抗炎药物、抗微生物药物和免疫抑制剂)结合使用。
  • 6,12-DINAPHTHYLCHRYSENE DERIVATIVE AND ORGANIC LIGHT-EMITTING DEVICE USING THE DERIVATIVE
    申请人:Iwawaki Hironobu
    公开号:US20120313083A1
    公开(公告)日:2012-12-13
    Provided are an organic compound having high heat stability suitable for use in an organic light-emitting device, and an organic light-emitting device using the organic compound. The organic light-emitting device is an organic light-emitting device, including: an anode; a cathode; and an organic compound layer disposed between the anode and the cathode, in which at least one layer of the organic compound layer has a 6,12-dinaphthylchrysene derivative represented by one of the following general formulae (1) and (2): in the formulae (1) and (2), Z represents a naphthyl group, and Q represents an electron-withdrawing substituent selected from the group consisting of the following general formulae (3) to (5): in the formula (5), R 1 represents a hydrogen atom or a methyl group.
    提供了一种具有高热稳定性的有机化合物,适用于有机发光器件,并提供了使用该有机化合物的有机发光器件。该有机发光器件包括:阳极;阴极;以及位于阳极和阴极之间的有机化合物层,在该有机化合物层的至少一层中具有以下一般式(1)和(2)所表示的6,12-二萘基蒽衍生物: 在式(1)和(2)中,Z代表萘基,Q代表从以下一般式(3)到(5)所选的电子吸引取代基: 在式(5)中,R1代表氢原子或甲基基团。
查看更多